ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Centre Georges Francois Leclerc · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
carcinomana
carcinoma, hepatocellular, fdg pet, fch pet, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 867757
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.